Dr. Michael Luggen
Dr. Luggen is a graduate of Harvard College and Columbia University College of Physicians and Surgeons. He completed his Internal Medicine Residency at the University of Cincinnati Hospitals and subsequently trained there as a fellow in the Division of Immunology under Evelyn V. Hess, MD. He joined the faculty after completion of his Fellowship as has been at UC ever since. He was appointed as Professor of Clinical Medicine in 2004. Dr. Luggen spends most of his time in the care of patients. The remainder of his time is equally divided between teaching and clinical research. His major research interest had been in the treatment of Rheumatoid Arthritis. Recently, however, he has become interested in SLE and has participated in several clinical trials designed to further the development of new treatments for lupus. In addition, he has begun collaborations on the immunogentics of SLE with investigators at Cincinnati Children’s Hospital Center for Autoimmune Genomics and Etiology and the Oklahoma Medical Research Foundation’s Lupus Family Registry and Repository. Dr. Luggen’s primary area of research in SLE has been in the area of cognitive dysfunction which affects a significant minority of patients and compromises profoundly the quality of their lives. He is attempting to understand what the risk factors are for this and how it impairs quality of life.